Currently a number of clinical conditions are known, in which it is necessary to maintain coagulation decreased. On one hand, these medications can be life-saving, on the other hand, their inappropriate dosage can be life-threatening.
Therefore it is essential to adhere to strict indications, intervals monitoring and the recommended therapeutic range when administering these medications. Laboratory monitoring of parameters of haemostasis during antithrombotic treatment or prevention in cardiology is a fundamental prerequisite for successful cardiologic intervention.